カテゴリー： QYResearch, 世界, 医療/バイオ

世界の経口薄膜医薬品製造市場インサイト及び予測（OTC、Rx）

◆英語タイトル：Global Oral Thin Film Drug Manufacturing Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10449）◆商品コード：QY22JLX10449
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：113
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、経口薄膜医薬品製造のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口薄膜医薬品製造の世界市場のxxx％を占める「OTC」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
経口薄膜医薬品製造の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの経口薄膜医薬品製造市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

経口薄膜医薬品製造のグローバル主要企業には、GSK、LTS、J&J、Indivior、Pfizer、Church & Dwight、tesa Labtec、Tapemark、Prestige、MonoSol、BioDelivery、Arx、ZIM、NAL Pharma、AdhexPharma、Aavishkar、IntelGenx Corp、APRなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

経口薄膜医薬品製造市場は、種類と用途によって区分されます。世界の経口薄膜医薬品製造市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
OTC、Rx

【用途別セグメント】
病院、ドラッグストア、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 経口薄膜医薬品製造製品概要
- 種類別市場（OTC、Rx）
- 用途別市場（病院、ドラッグストア、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の経口薄膜医薬品製造販売量予測2017-2028
- 世界の経口薄膜医薬品製造売上予測2017-2028
- 経口薄膜医薬品製造の地域別販売量
- 経口薄膜医薬品製造の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別経口薄膜医薬品製造販売量
- 主要メーカー別経口薄膜医薬品製造売上
- 主要メーカー別経口薄膜医薬品製造価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（OTC、Rx）
- 経口薄膜医薬品製造の種類別販売量
- 経口薄膜医薬品製造の種類別売上
- 経口薄膜医薬品製造の種類別価格
・用途別市場規模（病院、ドラッグストア、その他）
- 経口薄膜医薬品製造の用途別販売量
- 経口薄膜医薬品製造の用途別売上
- 経口薄膜医薬品製造の用途別価格
・北米市場
- 北米の経口薄膜医薬品製造市場規模（種類別、用途別）
- 主要国別の経口薄膜医薬品製造市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの経口薄膜医薬品製造市場規模（種類別、用途別）
- 主要国別の経口薄膜医薬品製造市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の経口薄膜医薬品製造市場規模（種類別、用途別）
- 主要国別の経口薄膜医薬品製造市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の経口薄膜医薬品製造市場規模（種類別、用途別）
- 主要国別の経口薄膜医薬品製造市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの経口薄膜医薬品製造市場規模（種類別、用途別）
- 主要国別の経口薄膜医薬品製造市場規模（トルコ、サウジアラビア）
・企業情報
GSK、LTS、J&J、Indivior、Pfizer、Church & Dwight、tesa Labtec、Tapemark、Prestige、MonoSol、BioDelivery、Arx、ZIM、NAL Pharma、AdhexPharma、Aavishkar、IntelGenx Corp、APR
・産業チェーン及び販売チャネル分析
- 経口薄膜医薬品製造の産業チェーン分析
- 経口薄膜医薬品製造の原材料
- 経口薄膜医薬品製造の生産プロセス
- 経口薄膜医薬品製造の販売及びマーケティング
- 経口薄膜医薬品製造の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 経口薄膜医薬品製造の産業動向
- 経口薄膜医薬品製造のマーケットドライバー
- 経口薄膜医薬品製造の課題
- 経口薄膜医薬品製造の阻害要因
・主な調査結果

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
Market Analysis and Insights: Global Oral Thin Film Drug Manufacturing Market
The global Oral Thin Film Drug Manufacturing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, OTC accounting for % of the Oral Thin Film Drug Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Oral Thin Film Drug Manufacturing market size is valued at US$ million in 2021, while the North America and Europe Oral Thin Film Drug Manufacturing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Thin Film Drug Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Thin Film Drug Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Thin Film Drug Manufacturing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Thin Film Drug Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Thin Film Drug Manufacturing market.
Global Oral Thin Film Drug Manufacturing Scope and Market Size
Oral Thin Film Drug Manufacturing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oral Thin Film Drug Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
OTC
Rx
Segment by Application
Hospitals
Drugstores
Others
By Company
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Thin Film Drug Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx
1.3 Market by Application
1.3.1 Global Oral Thin Film Drug Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Thin Film Drug Manufacturing Market Perspective (2017-2028)
2.2 Oral Thin Film Drug Manufacturing Growth Trends by Region
2.2.1 Oral Thin Film Drug Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oral Thin Film Drug Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Oral Thin Film Drug Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Oral Thin Film Drug Manufacturing Market Dynamics
2.3.1 Oral Thin Film Drug Manufacturing Industry Trends
2.3.2 Oral Thin Film Drug Manufacturing Market Drivers
2.3.3 Oral Thin Film Drug Manufacturing Market Challenges
2.3.4 Oral Thin Film Drug Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Thin Film Drug Manufacturing Players by Revenue
3.1.1 Global Top Oral Thin Film Drug Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Oral Thin Film Drug Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Oral Thin Film Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Thin Film Drug Manufacturing Revenue
3.4 Global Oral Thin Film Drug Manufacturing Market Concentration Ratio
3.4.1 Global Oral Thin Film Drug Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Thin Film Drug Manufacturing Revenue in 2021
3.5 Oral Thin Film Drug Manufacturing Key Players Head office and Area Served
3.6 Key Players Oral Thin Film Drug Manufacturing Product Solution and Service
3.7 Date of Enter into Oral Thin Film Drug Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Thin Film Drug Manufacturing Breakdown Data by Type
4.1 Global Oral Thin Film Drug Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Oral Thin Film Drug Manufacturing Forecasted Market Size by Type (2023-2028)
5 Oral Thin Film Drug Manufacturing Breakdown Data by Application
5.1 Global Oral Thin Film Drug Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Oral Thin Film Drug Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oral Thin Film Drug Manufacturing Market Size (2017-2028)
6.2 North America Oral Thin Film Drug Manufacturing Market Size by Type
6.2.1 North America Oral Thin Film Drug Manufacturing Market Size by Type (2017-2022)
6.2.2 North America Oral Thin Film Drug Manufacturing Market Size by Type (2023-2028)
6.2.3 North America Oral Thin Film Drug Manufacturing Market Share by Type (2017-2028)
6.3 North America Oral Thin Film Drug Manufacturing Market Size by Application
6.3.1 North America Oral Thin Film Drug Manufacturing Market Size by Application (2017-2022)
6.3.2 North America Oral Thin Film Drug Manufacturing Market Size by Application (2023-2028)
6.3.3 North America Oral Thin Film Drug Manufacturing Market Share by Application (2017-2028)
6.4 North America Oral Thin Film Drug Manufacturing Market Size by Country
6.4.1 North America Oral Thin Film Drug Manufacturing Market Size by Country (2017-2022)
6.4.2 North America Oral Thin Film Drug Manufacturing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oral Thin Film Drug Manufacturing Market Size (2017-2028)
7.2 Europe Oral Thin Film Drug Manufacturing Market Size by Type
7.2.1 Europe Oral Thin Film Drug Manufacturing Market Size by Type (2017-2022)
7.2.2 Europe Oral Thin Film Drug Manufacturing Market Size by Type (2023-2028)
7.2.3 Europe Oral Thin Film Drug Manufacturing Market Share by Type (2017-2028)
7.3 Europe Oral Thin Film Drug Manufacturing Market Size by Application
7.3.1 Europe Oral Thin Film Drug Manufacturing Market Size by Application (2017-2022)
7.3.2 Europe Oral Thin Film Drug Manufacturing Market Size by Application (2023-2028)
7.3.3 Europe Oral Thin Film Drug Manufacturing Market Share by Application (2017-2028)
7.4 Europe Oral Thin Film Drug Manufacturing Market Size by Country
7.4.1 Europe Oral Thin Film Drug Manufacturing Market Size by Country (2017-2022)
7.4.2 Europe Oral Thin Film Drug Manufacturing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Type
8.2.1 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oral Thin Film Drug Manufacturing Market Share by Type (2017-2028)
8.3 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Application
8.3.1 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oral Thin Film Drug Manufacturing Market Share by Application (2017-2028)
8.4 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Region
8.4.1 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oral Thin Film Drug Manufacturing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Thin Film Drug Manufacturing Market Size (2017-2028)
9.2 Latin America Oral Thin Film Drug Manufacturing Market Size by Type
9.2.1 Latin America Oral Thin Film Drug Manufacturing Market Size by Type (2017-2022)
9.2.2 Latin America Oral Thin Film Drug Manufacturing Market Size by Type (2023-2028)
9.2.3 Latin America Oral Thin Film Drug Manufacturing Market Share by Type (2017-2028)
9.3 Latin America Oral Thin Film Drug Manufacturing Market Size by Application
9.3.1 Latin America Oral Thin Film Drug Manufacturing Market Size by Application (2017-2022)
9.3.2 Latin America Oral Thin Film Drug Manufacturing Market Size by Application (2023-2028)
9.3.3 Latin America Oral Thin Film Drug Manufacturing Market Share by Application (2017-2028)
9.4 Latin America Oral Thin Film Drug Manufacturing Market Size by Country
9.4.1 Latin America Oral Thin Film Drug Manufacturing Market Size by Country (2017-2022)
9.4.2 Latin America Oral Thin Film Drug Manufacturing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Type
10.2.1 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oral Thin Film Drug Manufacturing Market Share by Type (2017-2028)
10.3 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Application
10.3.1 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oral Thin Film Drug Manufacturing Market Share by Application (2017-2028)
10.4 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Country
10.4.1 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oral Thin Film Drug Manufacturing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Oral Thin Film Drug Manufacturing Introduction
11.1.4 GSK Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 LTS
11.2.1 LTS Company Details
11.2.2 LTS Business Overview
11.2.3 LTS Oral Thin Film Drug Manufacturing Introduction
11.2.4 LTS Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.2.5 LTS Recent Developments
11.3 J&J
11.3.1 J&J Company Details
11.3.2 J&J Business Overview
11.3.3 J&J Oral Thin Film Drug Manufacturing Introduction
11.3.4 J&J Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.3.5 J&J Recent Developments
11.4 Indivior
11.4.1 Indivior Company Details
11.4.2 Indivior Business Overview
11.4.3 Indivior Oral Thin Film Drug Manufacturing Introduction
11.4.4 Indivior Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.4.5 Indivior Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Oral Thin Film Drug Manufacturing Introduction
11.5.4 Pfizer Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.5.5 Pfizer Recent Developments
11.6 Church & Dwight
11.6.1 Church & Dwight Company Details
11.6.2 Church & Dwight Business Overview
11.6.3 Church & Dwight Oral Thin Film Drug Manufacturing Introduction
11.6.4 Church & Dwight Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.6.5 Church & Dwight Recent Developments
11.7 tesa Labtec
11.7.1 tesa Labtec Company Details
11.7.2 tesa Labtec Business Overview
11.7.3 tesa Labtec Oral Thin Film Drug Manufacturing Introduction
11.7.4 tesa Labtec Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.7.5 tesa Labtec Recent Developments
11.8 Tapemark
11.8.1 Tapemark Company Details
11.8.2 Tapemark Business Overview
11.8.3 Tapemark Oral Thin Film Drug Manufacturing Introduction
11.8.4 Tapemark Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.8.5 Tapemark Recent Developments
11.9 Prestige
11.9.1 Prestige Company Details
11.9.2 Prestige Business Overview
11.9.3 Prestige Oral Thin Film Drug Manufacturing Introduction
11.9.4 Prestige Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.9.5 Prestige Recent Developments
11.10 MonoSol
11.10.1 MonoSol Company Details
11.10.2 MonoSol Business Overview
11.10.3 MonoSol Oral Thin Film Drug Manufacturing Introduction
11.10.4 MonoSol Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.10.5 MonoSol Recent Developments
11.11 BioDelivery
11.11.1 BioDelivery Company Details
11.11.2 BioDelivery Business Overview
11.11.3 BioDelivery Oral Thin Film Drug Manufacturing Introduction
11.11.4 BioDelivery Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.11.5 BioDelivery Recent Developments
11.12 Arx
11.12.1 Arx Company Details
11.12.2 Arx Business Overview
11.12.3 Arx Oral Thin Film Drug Manufacturing Introduction
11.12.4 Arx Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.12.5 Arx Recent Developments
11.13 ZIM
11.13.1 ZIM Company Details
11.13.2 ZIM Business Overview
11.13.3 ZIM Oral Thin Film Drug Manufacturing Introduction
11.13.4 ZIM Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.13.5 ZIM Recent Developments
11.14 NAL Pharma
11.14.1 NAL Pharma Company Details
11.14.2 NAL Pharma Business Overview
11.14.3 NAL Pharma Oral Thin Film Drug Manufacturing Introduction
11.14.4 NAL Pharma Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.14.5 NAL Pharma Recent Developments
11.15 AdhexPharma
11.15.1 AdhexPharma Company Details
11.15.2 AdhexPharma Business Overview
11.15.3 AdhexPharma Oral Thin Film Drug Manufacturing Introduction
11.15.4 AdhexPharma Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.15.5 AdhexPharma Recent Developments
11.16 Aavishkar
11.16.1 Aavishkar Company Details
11.16.2 Aavishkar Business Overview
11.16.3 Aavishkar Oral Thin Film Drug Manufacturing Introduction
11.16.4 Aavishkar Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.16.5 Aavishkar Recent Developments
11.17 IntelGenx Corp
11.17.1 IntelGenx Corp Company Details
11.17.2 IntelGenx Corp Business Overview
11.17.3 IntelGenx Corp Oral Thin Film Drug Manufacturing Introduction
11.17.4 IntelGenx Corp Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.17.5 IntelGenx Corp Recent Developments
11.18 APR
11.18.1 APR Company Details
11.18.2 APR Business Overview
11.18.3 APR Oral Thin Film Drug Manufacturing Introduction
11.18.4 APR Revenue in Oral Thin Film Drug Manufacturing Business (2017-2022)
11.18.5 APR Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の経口薄膜医薬品製造市場インサイト及び予測（OTC、Rx）(Global Oral Thin Film Drug Manufacturing Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の薄膜ドラッグデリバリー技術市場インサイト及び予測（経口薄膜、経皮吸収型フィルム、その他）
  • 世界の経口薄膜薬物送達技術市場インサイト及び予測（OTC、Rx）
  • 世界の経口薄膜薬物送達市場インサイト及び予測（OTC、Rx）
  • 世界の薄膜医薬品製造市場インサイト及び予測（口腔用薄膜、経皮用薄膜、その他）
  • 世界の薄膜ドラッグデリバリー市場インサイト及び予測（経口用薄膜、経皮用フィルム、その他）